• Extensive leadership experience acquired at a target, platform, and departmental level.
• High level of exposure to different facets of the drug discovery process from lead discovery to candidate selection. This has afforded a deep understanding on how to move compounds forward to the clinic.
• Project participation across a wide range of targets including kinases, serine/aspartyl proteases, GPCRs, matrix metalloproteases, and synthetases. Projects have covered multiple disease areas including virology, antibacterial, neuroscience, oncology, and rare diseases.